BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26552914)

  • 1. Late Recurrence After Radical Resection of Esophageal Cancer.
    Hiyoshi Y; Yoshida N; Watanabe M; Kurashige J; Karashima R; Iwagami S; Baba Y; Baba H
    World J Surg; 2016 Apr; 40(4):913-20. PubMed ID: 26552914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
    Chen G; Wang Z; Liu XY; Liu FY
    Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy.
    Chen G; Wang Z; Liu XY; Liu FY
    World J Surg; 2007 May; 31(5):1107-14. PubMed ID: 17426905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
    Chen G; Wang Z; Liu XY; Liu FY
    Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa-IVa lower thoracic oesophageal squamous cell carcinoma.
    Wang Y; Zhu L; Xia W; Wu L; Wang F
    World J Surg Oncol; 2018 Nov; 16(1):216. PubMed ID: 30404621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
    Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
    Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
    Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinoma.
    Yoshida N; Baba Y; Shigaki H; Harada K; Iwatsuki M; Sakamoto Y; Miyamoto Y; Kurashige J; Kosumi K; Tokunaga R; Watanabe M; Baba H
    Int J Clin Oncol; 2016 Dec; 21(6):1071-1078. PubMed ID: 27255393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy.
    Yamashita K; Watanabe M; Mine S; Kurogochi T; Okamura A; Hayami M; Imamura Y
    World J Surg; 2017 Sep; 41(9):2337-2344. PubMed ID: 28432391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic analysis of clinicopathological factors in patients after radical resection of esophageal carcinoma].
    Zhu SC; Song CL; Shen WB; Su JW; Li J; Liu ZK
    Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):281-6. PubMed ID: 22781041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the number of occult metastatic lymph nodes on postoperative relapse of resectable esophageal cancer.
    Morimoto J; Tanaka H; Ohira M; Kubo N; Muguruma K; Sakurai K; Yamashita Y; Maeda K; Sawada T; Hirakawa K
    Dis Esophagus; 2014 Jan; 27(1):63-71. PubMed ID: 23480452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Adjuvant Chemotherapy on Patients with Lymph Node-Positive Esophageal Cancer who are primarily Treated with Surgery.
    Pasquer A; Gronnier C; Renaud F; Duhamel A; Théreaux J; Carrere N; Gagniere J; Meunier B; Collet D; Mariette C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1340-9. PubMed ID: 26065869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection.
    Kosugi S; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
    Ann Surg Oncol; 2011 Oct; 18(10):2961-7. PubMed ID: 21499809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
    Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
    Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
    Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
    J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of upfront surgery for patients with unsuspected lymph node metastasis in esophageal cancer: a propensity scoring matching study.
    Park JK; Kim JJ; Moon SW; Cho DG
    J Cardiothorac Surg; 2018 Jun; 13(1):62. PubMed ID: 29880029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.